Ping Li

Ping Li

Auto-generated profile, based on publicly available information

Ping Li


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Journal of Food Biochemistry
Verified
Journal Article
Open access
PLPing Li
Ping Li
QSQile Song
Qile Song
FXFeng Xiaotong
Feng Xiaotong
YWYifan Wang
Yifan Wang
MCMei Chen
Mei Chen
QNQingbin Ni
Qingbin Ni
Spinal cord injury (SCI) as a serious neurological disease remains the great challenge for clinical therapy. Existing studies have confirmed that selenium (Se) supplementation could effectively decrease the risk of neurological diseases, but the mechanism is still unclear. Herein, a mouse SCI model was established, and the potential of selenomethionine (SeMet) against SCI was explored. Behavioral studies showed that SeMet administration in vivo effectively improved the motor symptoms of SCI mice. Mechanism investigation indicated that SeMet administration in vivo significantly blocked the decrease of neurons and Nissl bodies in SCI mice by inhibiting neural apoptosis. SeMet in vivo also dramatically attenuated oxidative damage of SCI mice by regulating the Nrf‐2/Keap‐1 pathway. Further studies revealed that SeMet in vivo significantly alleviated microglia activation and neuroinflammation in SCI mice, as demonstrated by the improved Iba‐1 and inflammatory factors expression, respectively. Moreover, SeMet in vivo apparently inhibited SCI‐induced cell ferroptosis of SCI mice by balancing ferroptosis‐related protein expression. Taken together, the results indicated that oxidative damage–mediated apoptosis and ferroptosis both contributed to the protective potential of SeMet against SCI, which validated the possibility that selenium‐containing agents could be promising drugs for SCI therapy.